Johnson Michael Perkins 4

4 · IDEXX LABORATORIES INC /DE · Filed Feb 18, 2025

Form 4

Period: 2025-02-13

Executive Vice President

Transactions

Exercise/Conversion
Common Stock
2025-02-14+176→ 406.342 total
Exercise/Conversion
Common Stock
2025-02-14+179→ 585.342 total
Tax Payment
Common Stock
2025-02-14$444.53/sh−118$52,455→ 467.342 total
Award
Non-Qualified Stock Option (right-to-buy)
2025-02-13+3,657→ 3,657 total
Exercise: $459.76Exp: 2035-02-12→ Common Stock (3,657 underlying)
Award
Incentive Stock Option (right-to-buy)
2025-02-13+217→ 217 total
Exercise: $459.76Exp: 2035-02-12→ Common Stock (217 underlying)
Award
Restricted Stock Unit
2025-02-13+870→ 870 total
→ Common Stock (870 underlying)
Exercise/Conversion
Restricted Stock Unit
2025-02-14−176→ 352 total
→ Common Stock (176 underlying)
Exercise/Conversion
Restricted Stock Unit
2025-02-14−179→ 535 total
→ Common Stock (179 underlying)

Footnotes (6)

[F1]Includes a total of 47 shares purchased under the Issuer Employee Stock Purchase Plan on March 29, 2024, June 28, 2024, September 31, 2024 and December 31, 2024.
[F2]Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2026.
[F3]Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2029.
[F4]Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2026.
[F5]Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2024.
[F6]Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning on February 14, 2025.

Documents

1 file